Sign up to our newsletter Subscribe
Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Sign up to our newsletter Subscribe
OHE’s Adrian Towse to speak on Options for the Sustainable Financing of Innovative Therapies. On Wednesday 14th October 2015, London School of Economics and Political Science and Imperial College London will joint host a forum on medical innovation. The title…
OHE’s Adrian Towse to speak on Options for the Sustainable Financing of Innovative Therapies.
On Wednesday 14th October 2015, London School of Economics and Political Science and Imperial College London will joint host a forum on medical innovation. The title of the forum is: Assessing Value and Sustainable Financing of Innovative Therapies.
This event is particularly timely as the number of innovative medical technologies addressing high unmet medical need and offering significant improvements in survival and patient quality of life has increased in recent years. The high cost and potential budget impact of these technologies has raised concern amongst some decision-makers.
The forum will be split into two panels:
The first panel is to focus on the value framework of innovative medical technologies. Professor Alistair McGuire (LSE Health) will present on this topic, and this will be followed by a discussion with six experts, including Professor Karl Claxton (University of York).
The second panel will focus on options for the sustainable financing of innovative therapies. A presentation will be given by Dr Panos Kanavos (LSE Health), followed by a discussion with another six experts. OHE’s Professor Adrian Towse, a visiting Professor at LSE, will feature on this panel.
For a previous presentation given by Adrian on a similar topic, see “Can we afford medical breakthroughs for large prevalence diseases? Lessons from hepatitis C”. In this presentation Adrian highlights a recent example in Europe of an expensive, yet very effective, and cost-effective, technology. He discusses methods which have been used to control affordability in the past, and stresses that the full implications (for example the impact on incentives and innovation) of these approaches must be considered. He explains that use of dynamic competition together with options for annualisation are more efficient routes to pay for expensive innovative technologies than budget caps.
The LSE-ICL medical innovation forum will be held at South Kensington Campus, Imperial College London, from 1.30-6.00PM.
Register for this event (free of charge) here.
View the full event invite here.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!